Research paperAntidepressant polypharmacy and the potential of pharmacokinetic interactions: DOXEPIN (cas 1668-19-5) but not mirtazapine causes clinically relevant changes in venlafaxine metabolism
-
Add time:10/01/2019 Source:sciencedirect.com
BackgroundTo uncover pharmacokinetic interactions between venlafaxine and DOXEPIN (cas 1668-19-5) or mirtazapine in a naturalistic sample.
We also recommend Trading Suppliers and Manufacturers of DOXEPIN (cas 1668-19-5). Pls Click Website Link as below: cas 1668-19-5 suppliers
Prev:Physicochemical evaluation and non-isothermal kinetic study of the drug–excipient interaction between DOXEPIN (cas 1668-19-5) and lactose
Next:Chapter 1 Benzoheteropines with Fused Pyrrole, Furan and Thiophene Rings) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Physicochemical evaluation and non-isothermal kinetic study of the drug–excipient interaction between DOXEPIN (cas 1668-19-5) and lactose09/27/2019
- Clinical reviewDOXEPIN (cas 1668-19-5) for insomnia: A systematic review of randomized placebo-controlled trials09/26/2019
- Original Research ArticleHighly sensitive LC–MS/MS method to estimate DOXEPIN (cas 1668-19-5) and its metabolite norDOXEPIN (cas 1668-19-5) in human plasma for a bioequivalence study09/25/2019
- Document headingTherapeutic rationale for low dose DOXEPIN (cas 1668-19-5) in insomnia patients09/24/2019
- Comparing DOXEPIN (cas 1668-19-5) cream to oral antihistamines for the treatment of itch in burn patients: A multi-center triple-blind randomized controlled trial09/10/2019